Plunkett Research Online: Dendreon Corporation

DENDREON CORPORATION (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Dendreon Corporation discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic, me.....


DENDREON CORPORATION

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 256-4545
Fax: 206 256-0571
Address: 1208 Eastlake Ave. E.
Seattle, WA 98102 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Nanjing Xinjiekou Department Store Co

ContactsDescription

Jim CaggianoCEO
Andrew SandlerChief Medical Officer/Executive VP
See More
Dendreon Corporation discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic, me.....See More See More

$USD, In whole numbers 2018201720162015201420132012
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture